Showing results (161-170 of 315) with videos related to

Sort By:
Pageof 32
Haematologica|December 5, 2024
Does size matter? Center-specific characteristics and survival after allogeneic hematopoietic cell transplantation for acute myeloid leukemia: an analysis of the German Registry for Stem Cell Transplantation and Cell TherapyWolfgang Bethge, Sarah Flossdorf, Franziska Hanke, et al.
Blood Advances|June 12, 2026
High-risk single-refractory and double-refractory chronic lymphocytic leukemia: feasibility and impact of alloHCTJoseph Kauer, Isabelle Krämer, Patrick Derigs, et al.
Frontiers in Immunology|January 30, 2018
Differences in Expansion Potential of Naive Chimeric Antigen Receptor T Cells from Healthy Donors and Untreated Chronic Lymphocytic Leukemia PatientsJean-Marc Hoffmann, Maria-Luisa Schubert, Lei Wang, et al.
BMJ Open|May 22, 2019
Treatment of patients with relapsed or refractory CD19+ lymphoid disease with T lymphocytes transduced by RV-SFG.CD19.CD28.4-1BBzeta retroviral vector: a unicentre phase I/II clinical trial protocolMaria-Luisa Schubert, Anita Schmitt, Leopold Sellner, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 20, 2010
NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on disease-specific methods and strategies for monitoring relapse following allogeneic stem cell transplantation. part II: chronic leukemias, myeloproliferative neoplasms, and lymphoid malignanciesNicolaus Kröger, Ulrike Bacher, Peter Bader, et al.
Blood|January 31, 2013
Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMTEsa Jantunen, Ariane Boumendil, Herve Finel, et al.
Leukemia|June 25, 2024
How risky is a second allogeneic stem cell transplantation?Olaf Penack, Mouad Abouqateb, Christophe Peczynski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2008
Allogeneic hematopoietic stem-cell transplantation for chronic lymphocytic leukemia with 17p deletion: a retrospective European Group for Blood and Marrow Transplantation analysisJohannes Schetelig, Anja van Biezen, Ronald Brand, et al.
International Journal of Oncology|March 16, 2022
Comparison of single copy gene‑based duplex quantitative PCR and digital droplet PCR for monitoring of expansion of CD19‑directed CAR T cells in treated patientsMaria-Luisa Schubert, Carolina Berger, Alexander Kunz, et al.
Vaccines|February 26, 2022
Humoral Responses and Chronic GVHD Exacerbation after COVID-19 Vaccination Post Allogeneic Stem Cell TransplantationCaroline Pabst, Louise Benning, Nora Liebers, et al.
Pageof 32